secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2021-09-13T23:59:59+00:00
Accession:  0001683168-21-004239
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cannabics Pharmaceuticals appoints Gabriel Yariv as Executive Chairman
----------------------------------------------------------------------

- Gabriel Yariv appointed as Executive Chairman effective September 3, 2021.
- Yariv brings over 20 years experience in medical industry; co-founded BreathID (now Medtronic) and SimuTec.
- Yariv will continue as Director and Chief Operational Executive while serving as Executive Chair.
- Appointment made by unanimous board resolution on September 3, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821004239/0001683168-21-004239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316821004239/cannabics_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-004239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer